Teva Pharmaceutical Industries Pre-Paid Expenses 2010-2024 | TEVA
Teva Pharmaceutical Industries pre-paid expenses for the quarter ending June 30, 2024 were $1.096B, a 10.75% decline year-over-year.
- Teva Pharmaceutical Industries pre-paid expenses for 2023 were $1.255B, a 8% increase from 2022.
- Teva Pharmaceutical Industries pre-paid expenses for 2022 were $1.162B, a 8.09% increase from 2021.
- Teva Pharmaceutical Industries pre-paid expenses for 2021 were $1.075B, a 13.76% increase from 2020.